“Tapeworm Drug Shows Early Promise in Treating Endometriosis, Study Finds” — what this page in the network covers. Researchers have discovered that a common tapeworm treatment may hold the key to combating endometriosis, a painful condition affecting millions of women worldwide. The drug, known as niclosamide, has shown early effectiveness in reducing the growth of endometrial tissue outside the uterus, according to new findings. Endometriosis occurs when tissue similar to the uterine lining grows elsewhere, causing severe pelvic pain, heavy periods, and infertility.
Current treatments are limited to pain management, hormone therapy, or surgery, often with significant side effects or recurrence. Niclosamide, already approved for human use against tapeworms, appears to target the cellular mechanisms driving endometriosis lesions. In laboratory models, the drug inhibited the proliferation of endometrial cells and reduced inflammation, suggesting a potential new therapeutic avenue. The full version stays on the original page, which this listing opens directly.